Press release
Galactosidase Market Size to Boost USD 2.90 Billion By 2032 | CAGR 6.3% - Published by Emergen Research
The global Galactosidase market size was USD 1.58 Billion in 2022 and is expected to register a rapid revenue CAGR of 6.3% during the forecast period. Rising demand for galactosidase from the Food & Beverage (F&B) industry and medical applications such as blood group conversion and rapid advancements in enzyme technology are key factors driving market revenue growth.
The galactosidase market encompasses enzymes used in various industrial applications, particularly in the food and beverage, pharmaceutical, and biotechnology sectors. Galactosidase enzymes, including α-galactosidase and β-galactosidase, play a crucial role in catalyzing the hydrolysis of galactosides into simpler sugars, such as glucose and galactose. This enzymatic activity finds widespread use in food processing, lactose intolerance management, and bioprocessing applications, driving the demand for galactosidase enzymes worldwide.
The report is attuned with the latest market changes and economic landscape with regard to the currently unfolding COVID-19 pandemic. The crisis has affected the demand and supply pattern, as well as the trends of the industry. It has also brought an economic slowdown that has affected the business of the key manufacturers of the industry. The report estimates the impact of this crisis on the current scenario and future prospects and provides a post-COVID market scenario.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/2854
Drivers of the Galactosidase Market :
Several factors drive the growth of the galactosidase market. In the food and beverage industry, the increasing demand for enzyme-modified products, including lactose-free dairy products and fruit juices, fuels the demand for galactosidase enzymes. Moreover, the rising prevalence of lactose intolerance among consumers has spurred the development of enzyme-based dietary supplements and digestive aids containing galactosidase to alleviate symptoms. Additionally, advancements in enzyme engineering and bioprocessing technologies have expanded the application scope of galactosidase enzymes in pharmaceuticals, biofuels, and other industrial sectors, driving market growth.
Growth Factors of the Galactosidase Market :
The galactosidase market is driven by various growth factors contributing to its expansion. One key factor is the growing consumer awareness and demand for clean-label and natural ingredients in food and beverage products, driving the adoption of enzyme-based solutions like galactosidase enzymes as alternatives to chemical additives. Furthermore, the increasing prevalence of lactose intolerance and dairy-related digestive disorders globally creates a significant market opportunity for galactosidase enzyme products designed to improve digestibility and enhance nutritional profiles. Additionally, ongoing research and development efforts aimed at enhancing the specificity, activity, and stability of galactosidase enzymes are expected to fuel market growth by expanding their application potential across diverse industries.
Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/2854
The report also discusses the key players involved in the market such as:
Biocompare, Megazyme Ltd., JINAN BESTZYME BIOENGINEERING CO., LTD., Prospec-Tany Technogene Ltd., Pharming Group N.V., ISU ABXIS, Protalix Biotherapeutics, Chiesi Limited, Aumgene Biosciences, Amano Enzyme, Inc., Novozymes, Bestochem, DuPont, Konochem Co., Ltd., Sangamo Therapeutics, Inc.
The report provides a thorough estimation of the overall impact of the pandemic on the Galactosidase Market and its vital segments. The report also discusses the impact of the pandemic across different regions of the market. It also offers a current and future assessment of the impact of the pandemic on the Galactosidase Market
Galactosidase Latest Industry Updates
On 5 May 2023, Chiesi announced the signing of Global Rare Strategies, a business unit of the Chiesi Group that provides innovative treatments and solutions for people with rare diseases. Protalix BioTherapeutics, Inc. ProCellEx enriches therapeutic proteins expressed through the proprietary plant cell-based expression system ProCellEx, which the European Commission (EC) has approved in the European Union (EU) for treatment of adult Fabry disease patients with PRX-102 (pegnigalsidase alfa) has been granted marketing approval.
On 22 February 2023, Sangamo Therapeutics, Inc., a genomic medicine company, announced updated preliminary data as of October 20, 2022, from the Phase 1/2 clinical study of STAAR evaluates isaralgagene civaparvovec, or ST-920, a wholly owned Gene therapy product candidate for the treatment of Fabry disease. These data, presenting new biomarker data and results from the first kidney biopsy in this study, show evidence of clinical benefit of isaralgagene civaparvovec in Fabry disease.
Direct Order Can Be Placed Through This Link [Exclusive Copy] @ https://www.emergenresearch.com/select-license/2854
Galactosidase Market Segment Analysis :
For the purpose of this report, Emergen Research has segmented the global galactosidase market on the basis of product, form, application, and region:
Product Outlook (Revenue, USD Billion; 2019-2032)
Alpha Galactosidase
Beta Galactosidase
Form Outlook (Revenue, USD Billion; 2019-2032)
Capsule
Tablet
Others
Application Outlook (Revenue, USD Billion; 2019-2032)
Food & Beverages (F&B)
Pharmaceuticals
Pulp and Paper
Feed
Others
Regional Outlook (Revenue, USD Billion; 2019-2032)
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Benelux
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Rest of APAC
Latin America
Brazil
Rest of LATAM
Middle East & Africa
Saudi Arabia
UAE
South Africa
Turkey
Rest of Middle East & Africa
Browse Full Report Description + Research Methodology + Table of Content + Infographics @ https://www.emergenresearch.com/industry-report/galactosidase-market
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights
About Us:
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
The galactosidase market encompasses enzymes used in various industrial applications, particularly in the food and beverage, pharmaceutical, and biotechnology sectors. Galactosidase enzymes, including α-galactosidase and β-galactosidase, play a crucial role in catalyzing the hydrolysis of galactosides into simpler sugars, such as glucose and galactose. This enzymatic activity finds widespread use in food processing, lactose intolerance management, and bioprocessing applications, driving the demand for galactosidase enzymes worldwide.
The report is attuned with the latest market changes and economic landscape with regard to the currently unfolding COVID-19 pandemic. The crisis has affected the demand and supply pattern, as well as the trends of the industry. It has also brought an economic slowdown that has affected the business of the key manufacturers of the industry. The report estimates the impact of this crisis on the current scenario and future prospects and provides a post-COVID market scenario.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/2854
Drivers of the Galactosidase Market :
Several factors drive the growth of the galactosidase market. In the food and beverage industry, the increasing demand for enzyme-modified products, including lactose-free dairy products and fruit juices, fuels the demand for galactosidase enzymes. Moreover, the rising prevalence of lactose intolerance among consumers has spurred the development of enzyme-based dietary supplements and digestive aids containing galactosidase to alleviate symptoms. Additionally, advancements in enzyme engineering and bioprocessing technologies have expanded the application scope of galactosidase enzymes in pharmaceuticals, biofuels, and other industrial sectors, driving market growth.
Growth Factors of the Galactosidase Market :
The galactosidase market is driven by various growth factors contributing to its expansion. One key factor is the growing consumer awareness and demand for clean-label and natural ingredients in food and beverage products, driving the adoption of enzyme-based solutions like galactosidase enzymes as alternatives to chemical additives. Furthermore, the increasing prevalence of lactose intolerance and dairy-related digestive disorders globally creates a significant market opportunity for galactosidase enzyme products designed to improve digestibility and enhance nutritional profiles. Additionally, ongoing research and development efforts aimed at enhancing the specificity, activity, and stability of galactosidase enzymes are expected to fuel market growth by expanding their application potential across diverse industries.
Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/2854
The report also discusses the key players involved in the market such as:
Biocompare, Megazyme Ltd., JINAN BESTZYME BIOENGINEERING CO., LTD., Prospec-Tany Technogene Ltd., Pharming Group N.V., ISU ABXIS, Protalix Biotherapeutics, Chiesi Limited, Aumgene Biosciences, Amano Enzyme, Inc., Novozymes, Bestochem, DuPont, Konochem Co., Ltd., Sangamo Therapeutics, Inc.
The report provides a thorough estimation of the overall impact of the pandemic on the Galactosidase Market and its vital segments. The report also discusses the impact of the pandemic across different regions of the market. It also offers a current and future assessment of the impact of the pandemic on the Galactosidase Market
Galactosidase Latest Industry Updates
On 5 May 2023, Chiesi announced the signing of Global Rare Strategies, a business unit of the Chiesi Group that provides innovative treatments and solutions for people with rare diseases. Protalix BioTherapeutics, Inc. ProCellEx enriches therapeutic proteins expressed through the proprietary plant cell-based expression system ProCellEx, which the European Commission (EC) has approved in the European Union (EU) for treatment of adult Fabry disease patients with PRX-102 (pegnigalsidase alfa) has been granted marketing approval.
On 22 February 2023, Sangamo Therapeutics, Inc., a genomic medicine company, announced updated preliminary data as of October 20, 2022, from the Phase 1/2 clinical study of STAAR evaluates isaralgagene civaparvovec, or ST-920, a wholly owned Gene therapy product candidate for the treatment of Fabry disease. These data, presenting new biomarker data and results from the first kidney biopsy in this study, show evidence of clinical benefit of isaralgagene civaparvovec in Fabry disease.
Direct Order Can Be Placed Through This Link [Exclusive Copy] @ https://www.emergenresearch.com/select-license/2854
Galactosidase Market Segment Analysis :
For the purpose of this report, Emergen Research has segmented the global galactosidase market on the basis of product, form, application, and region:
Product Outlook (Revenue, USD Billion; 2019-2032)
Alpha Galactosidase
Beta Galactosidase
Form Outlook (Revenue, USD Billion; 2019-2032)
Capsule
Tablet
Others
Application Outlook (Revenue, USD Billion; 2019-2032)
Food & Beverages (F&B)
Pharmaceuticals
Pulp and Paper
Feed
Others
Regional Outlook (Revenue, USD Billion; 2019-2032)
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Benelux
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Rest of APAC
Latin America
Brazil
Rest of LATAM
Middle East & Africa
Saudi Arabia
UAE
South Africa
Turkey
Rest of Middle East & Africa
Browse Full Report Description + Research Methodology + Table of Content + Infographics @ https://www.emergenresearch.com/industry-report/galactosidase-market
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights
About Us:
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage
to this press release on woodPRI. woodPRI disclaims liability for any content contained in
this release.
Recommend
/newsMicroencapsulation Market Deep Analysis on Key Players - Dow Corning, Encapsys, Syngenta Crop Protection, Evonik Industries, 3M and Bayer
Market Study Report Adds Global Microencapsulation Market Size, Status and Forecast 2024 added to its database. The report provides key statistics on the current state of the industry and other analytical data to understand the market.
Extensive research is required for choosing the appropriate cor...
/newsGermany Airbag Market Size 2023: Global Share, Industry And Report Analysis By 2030 | Hyundai Mobis Co., Ltd. Key Safety Systems, Inc. Robert Bosch GmbH
Germany airbag market is expected to grow at a CAGR of around 6% during the forecast period. Germany Airbag Market research report refers to gathering and analyzing significant market data serve as best medium for various industry players to launch novel product or service. It is vital for key firms...
/newsSecurities Brokerages And Stock Exchanges Market Outlook 2021: Big Things are Happening
A new intelligence report released by HTF MI with title "Global Securities Brokerages And Stock Exchanges Market Survey & Outlook" is designed covering micro level of analysis by Insurers and key business segments, offerings and sales channels. The Global Securities Brokerages And Stock Exchange...
/newsRenewable Chemicals Market Emerging Trends and Competitive Landscape Forecast to 2028
The renewable chemicals market was valued at US$ 80,566.30 million in 2021 and is projected to reach US$ 1,76,750.76 million by 2028 it is expected to grow at a CAGR of 11.9% from 2021 to 2028. The research report focuses on the current market trends, opportunities, future potential of the market, a...
/newsHow Coronavirus is Impacting Cold Brew Coffee, Global Market Volume Analysis, Size, Share and Key Trends 2020-2026
"Market Latest Research Report 2020:
Los Angles United States, February 2020: The Cold Brew Coffee market has been garnering remarkable momentum in the recent years. The steadily escalating demand due to improving purchasing power is projected to bode well for the global market. QY Research's lates...
/newsCorporate E-Learning Market - Global Industry Size, Share, Key Players Analysis that are Infor, SkillSoft Corporation, Adrenna, CERTPOINT Systems and others with Regional Forecast to 2022
Overview:
E-Learning is used to enhance the learning procedures for newer job requirements and to make employees sound about the internal and external changes in the market and respective organizations. This method has created considerable differences in the ways of training and developing employee...
